Clinical Trial Update: Trial of Endostar Combined With CHOPT for T Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Endostar in combination with CHOPT chemotherapy for T-cell lymphoma. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Endostar (recombinant human endostatin)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)
• Vincristine (vincristine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: T Cell Lymphoma | Phase 2 | Status: UNKNOWN